Hidden Zeeman Field in Odd-Parity Magnets: An Ideal Platform for Topological Superconductivity
Physical Review Letters · 23.09.2026 · 137 (13)
DOI: 10.1103/j9m4-386b ↗Kurz gefasst
Fachartikel in der Zeitschrift Physical Review Letters, online erschienen am 23.09.2026. Verfasst von Xun-Jiang Luo und 4 weiteren Autor:innen. Beteiligte Einrichtung: HFIPS, High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei, Anhui 230031, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 73 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Chinese Academy of Sciences, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- HFIPS, High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei, Anhui 230031, China.
- Hong Kong University of Science and Technology, Department of Physics, Clear Water Bay, 999077 Hong Kong, China.
Förderung
- National Key Research and Development Program of China
- Chinese Academy of Sciences
- National Natural Science Foundation of China
- Ministry of Science and Technology of the People’s Republic of China
- Research Grants Council, University Grants Committee
- New Cornerstone Foundation
Zitieren
APA
Luo, X. J., Sun, Z. T., Feng, X., Tian, M., & Law, K. T. (2026). Hidden Zeeman Field in Odd-Parity Magnets: An Ideal Platform for Topological Superconductivity. Physical Review Letters, 137(13). https://doi.org/10.1103/j9m4-386b
Vancouver
Luo XJ, Sun ZT, Feng X, Tian M, Law KT. Hidden Zeeman Field in Odd-Parity Magnets: An Ideal Platform for Topological Superconductivity. Physical Review Letters. 2026;137(13). doi:10.1103/j9m4-386b
BibTeX
@article{Luo2026,
author = {Luo, Xun-Jiang and Sun, Zi-Ting and Feng, Xilin and Tian, Mingliang and Law, K T},
title = {Hidden Zeeman Field in Odd-Parity Magnets: An Ideal Platform for Topological Superconductivity},
journal = {Physical Review Letters},
year = {2026},
volume = {137},
number = {13},
doi = {10.1103/j9m4-386b}
}
EUVIMED